Haplogen
Haplogen is a young biopharmaceutical company with the mission to improve human health by combating infectious disease.
Date | Investors | Amount | Round |
---|---|---|---|
£6.0m | Acquisition | ||
€70.0k | Grant | ||
Total Funding | $77.0k |
Date | Investors | Amount | Round |
---|---|---|---|
£6.0m | Acquisition | ||
€70.0k | Grant | ||
Total Funding | $77.0k |